Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae
Usage of cephalosporin and quinolone antibiotics has aggravated the development of extended-spectrum beta-lactamase (ESBL)–producing quinolone-resistant (QR) pathogenic Enterobacteriaceae. The present study aims to determine antimicrobial activity of cinnamaldehyde alone or in combination with cefotaxime/ciprofloxacin to reverse the drug resistance and evaluations of efficacy, and possible molecular mechanism of action of the combination was also evaluated using in vitro assays. Broth microdilution assay was used to determine minimum inhibitory concentrations (MICs) of cinnamaldehyde and antibiotics against ESBL-QR Enterobacteriaceae. Synergistic effect and dynamic interaction with antibiotics were further examined by checkerboard assay, isobologram analysis, and time-kill assay, respectively. Cellular morphology of bacteria was viewed with scanning electron microscopy (SEM). Effects of cinnamaldehyde and its combination on the expression of gene encoding—porins (ompC, ompF, ompK35, and ompK36), efflux pump genes (acrB–E. coli, acrB–K. pneumoniae), and antibiotic-resistant genes (blaTEM, blaSHV, blaCTXM, and QnrB) were evaluated using real-time quantitative PCR (RT-qPCR). Majority of the E. coli (32.1%) and K. pneumoniae (24.2%) isolates demonstrated MIC of cinnamaldehyde at 7.34 μg/mL and 0.91 g/mL, respectively. Synergism between cinnamaldehyde and cefotaxime was noted among 75% E. coli and 60.6% K. pneumoniae. Similarly, synergism with ciprofloxacin was observed among 39.6% and 42.4% of the bacteria, respectively. Thus, cinnamaldehyde reduced MIC of cefotaxime and ciprofloxacin 2–1024-fold with bactericidal and/synergistic effect after 24 h. Cinnamaldehyde and its combination altered gene expression by ~ 1.6 to ~ 400-fold. Distorted bacterial cell structures were visible after treatment with cinnamaldehyde and/or with cefotaxime/ciprofloxacin. The results indicated the potential efficacy and mode of action of cinnamaldehyde alone and in combination with antibiotics against pathogenic ESBL-QR bacteria.
KeywordsCinnamaldehyde ESBL Quinolone Synergy Scanning electron microscopy Real-time quantitative PCR
The authors are extremely grateful to the Director, Calcutta School of Tropical Medicine, Kolkata, India, for providing necessary facilities for this study.
This study is funded by the Indian Council of Medical Research (Grant No. -58/67/BMS-2012).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement and informed consent
The study was approved by the ethical research committee (reference number: CREC-STM/53 dated 23/09/2011). Informed consent was obtained from the patients for participating in the study.
- 1.Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR (2017) Antimicrobial resistance and he alternative resources with special emphasis on plant-based antimicrobials-a review. Plants (Basel) 10(2):6Google Scholar
- 5.van Hoek Angela HAM, Mevius D, Guerra B, Mullany P, Roberts Paul A, Aarts Henk JM (2011) Acquired antibiotic resistance genes: an overview. Front Microbiol 2:1–27Google Scholar
- 12.Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, Document M100-S18. CLSI, Wayne, PAGoogle Scholar
- 13.Garcia L (2010) Synergism testing: broth microdilution checkerboard and broth macrodilution methods. In: Garcia L (ed) Clinical microbiology procedures handbook, 3rd edn. ASM Press, Washington, pp 140–162Google Scholar
- 14.Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacolo Rev 58:31Google Scholar
- 17.Cui Y, Kim SH, Kim H, Yeom J, Ko K et al (2012) AFM probing the mechanism of synergistic effects of the green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. PLoS One 7:e48880CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Justice SS, Hunstad DA, Cegelski L, Hultgren SJ (2008) Morphological plasticity as a bacterial survival strategy. Nature 6:162–168Google Scholar
- 24.Raja SB, Murali MR, Devaraj SN (2008) Differential expression of OmpC and OmpF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aeglemarmelos, altering its susceptibility toward beta-lactam antibiotics. Diagn Microbiol Infect Dis 61:321–328CrossRefPubMedGoogle Scholar
- 27.Zhou X, Jia F, Liu X, Wang Y (2012) Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates. Phytother Res 261637–43Google Scholar
- 29.National Toxicology Program (2004) NTP toxicology and carcinogenesis studies of trans-cinnamaldehyde (CAS no. 14371-10-9) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser 514:1–281Google Scholar